Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours

Ann Oncol. 2008 Sep:19 Suppl 7:vii146-52. doi: 10.1093/annonc/mdn476.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Drug Delivery Systems / adverse effects*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / adverse effects
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Vascular Endothelial Growth Factor A
  • ErbB Receptors
  • Receptor, ErbB-2